Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Opium Tincture vs Methadone for Opioid Use Disorder
NCT02502175Phase 3Completed
- Sponsor
- University of British Columbia
- Start
- Jun 2017
- Primary completion
- Mar 2018
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of opium tincture in opioid use disorder (OUD), sponsored by University of British Columbia. Started Jun 2017; status: completed.
02
Drugs
opium tincture
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT02502175.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02502175.